During cancer progression, antigens released by dying tumor cells are presented by antigen-presenting cells (APCs) to CD4+ or CD8+ T cells, resulting in immune activation and a cascade of events that are the foundation of cancer immunity [46]. This evidence concerns the gene CD8A and neoplasm.